Mata, Christopher .
HRN: 24-96-32 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2025
CEFTRIAXONE 1G (VIAL)
01/18/2025
01/25/2025
IVTT
2 Gm
Q 24h
Acute Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes